Imaging may help predict NSCLC response to chemoradiotherapy

07/22/2013 |

A study in the Journal of Nuclear Medicine reported on the efficacy of F-18 FDG PET in predicting non-small cell lung cancer response to concomitant chemoradiotherapy. Researchers performed FDG PET scans on 28 patients before treatment, at the end of the second week of treatment and two weeks and three months after the completion of treatment. "The current study in locally advanced NSCLC patients treated with concomitant chemoradiotherapy indicates that early in treatment F-18 FDG PET can be used to predict outcome," researchers wrote.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX